Schepis et al., 2009 - Google Patents
Herpes simplex virus infection downmodulates NKG2D ligand expressionSchepis et al., 2009
View PDF- Document ID
- 11939569416987475071
- Author
- Schepis D
- D’amato M
- Studahl M
- Bergström T
- Kärre K
- Berg L
- Publication year
- Publication venue
- Scandinavian journal of immunology
External Links
Snippet
Herpes simplex virus (HSV) type 1 infection may cause orofacial infections in humans. The virus resides in a latent form in neural ganglia and occasionally reactivates and infects epithelial cells. Natural killer (NK) cells have been implicated in immune control of herpes …
- 102100012223 KLRK1 0 title abstract description 54
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schepis et al. | Herpes simplex virus infection downmodulates NKG2D ligand expression | |
Budhwani et al. | Plasticity of type I interferon-mediated responses in cancer therapy: from anti-tumor immunity to resistance | |
Ma et al. | PD-1/CTLA-4 blockade inhibits Epstein-Barr virus-induced lymphoma growth in a cord blood humanized-mouse model | |
Green et al. | Murine B cell response to TLR7 ligands depends on an IFN-β feedback loop | |
Hart et al. | TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-γ production | |
Hong et al. | Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model | |
Loh et al. | Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver | |
Mossman et al. | Herpesviruses and the innate immune response | |
Liu et al. | The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component | |
Li et al. | Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5 | |
Schlee et al. | c‐MYC activation impairs the NF‐κB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma | |
Lee et al. | Modulation of immune system by Kaposi’s sarcoma-associated herpesvirus: lessons from viral evasion strategies | |
Moghoofei et al. | Epstein–Barr virus and thyroid cancer: The role of viral expressed proteins | |
Grauwet et al. | Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1–dependent NK cell-mediated lysis of infected cells | |
Ilcus et al. | Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies | |
Genovese et al. | Cell-mediated immunity in elite controllers naturally controlling HIV viral load | |
Schmiedel et al. | Human herpesvirus 6B downregulates expression of activating ligands during lytic infection to escape elimination by natural killer cells | |
Ahmad et al. | Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction | |
Klapproth et al. | The IKK2/NF-κB pathway suppresses MYC-induced lymphomagenesis | |
Sathish et al. | Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview | |
Campbell et al. | Varicella-zoster virus and herpes simplex virus 1 differentially modulate NKG2D ligand expression during productive infection | |
Wu et al. | Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses | |
Kather et al. | Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences | |
Zhang et al. | T follicular helper cells restricted by IRF8 contribute to T cell-mediated inflammation | |
Iwata et al. | Antitumor activities of valproic acid on Epstein–Barr virus‐associated T and natural killer lymphoma cells |